Previous Section | Index | Home Page |
10 Mar 2009 : Column 373Wcontinued
Norman Lamb: To ask the Secretary of State for Health how many cases there were of (a) mumps, ( b) whooping cough, (c) typhoid, (d) scarlet fever, (e) cholera, (f) diphtheria, (g) leprosy, (h) botulism, (i) listeria, (j) tuberculosis, (k) polio and (l) typhus in each strategic health authority in each of the last five years. [261488]
Dawn Primarolo: The available information has been placed in the Library.
Mike Penning: To ask the Secretary of State for Health on what occasions other than meetings of the EU Council of Ministers, Ministers from his Department expect to meet the European Commissioner for Health over the next six months. [262095]
Dawn Primarolo: There are currently no plans to hold a meeting, in the coming six months, between Health Ministers and the European Commissioner for Health, other than at the EU Council of Ministers. Such a meeting can be arranged as the need arises. The United Kingdom will however continue to engage regularly with the Commission and other EU member states at official level in the Health Council Working Group.
Mr. Laurence Robertson: To ask the Secretary of State for Health how much NHS funding was provided for (a) research into and (b) treatment of premature ovarian failure in (i) Gloucestershire and (ii) England in the latest period for which figures are available; and if he will make a statement. [260994]
Dawn Primarolo: The Department funds national health service research and development through the National Institute for Health Research (NIHR). The Institutes research programmes support high quality research of relevance and in areas of high priority to patients and the NHS. None of this research is at present concerned specifically with premature ovarian failure.
The Medical Research Council (MRC) is the other main agency through which the Government support medical and clinical research. The MRC is an independent body that receives its grant-in-aid from the Department for Innovation, Universities and Skills.
The MRC is currently funding four research projects of relevance to premature ovarian failure on which £1.1 million was spent in 2007-08. It also supports a large portfolio of reproductive tract research and underpinning reproductive medicine research.
Details of NHS expenditure on the treatment of women with premature ovarian failure are not centrally available.
Mr. Lansley: To ask the Secretary of State for Health what steps he plans to take to increase the (a) number and (b) skills level of public health workers as proposed in A High Quality Workforce: NHS Next Stage Review. [260827]
Ann Keen: In order to ensure that the actions we are setting in train to deliver the numbers and skills required in the public health workforce are aligned and coherent with our system policies, we have commissioned an internal review. This will examine the effectiveness of existing policies and initiatives in place across the Department and will provide an informed assessment of the capacity requirements and skills gaps of the public health delivery system.
The team supporting this review is now in place and has commenced work, engaging across the Department and with key external stakeholders. The timetable they are working to will result in the publication of findings late in the year, to inform planning cycles for the public health delivery systems.
Mr. Lansley: To ask the Secretary of State for Health what the multi-professional education and training budget for each strategic health authority was in each year since 1997. [260846]
Ann Keen: Information on the multi professional education and training budget has been collected only on a comparable basis since 2003-04 financial year. The sums allocated to each strategic health authority (SHA) are shown in the following tables:
Multi professional education and training allocations by SHA, 2008-09 | |
SHA | Allocation (£000) |
Next Section | Index | Home Page |